An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
暂无分享,去创建一个
Jonathan C. Cohen | D. Cox | R. Krauss | M. Olivier | L. Pennacchio | E. Rubin | J. Hubacek | J. Fruchart | R M Krauss | D R Cox | J C Fruchart | L A Pennacchio | M Olivier | J A Hubacek | J C Cohen | E M Rubin
[1] J. Breslow,et al. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. , 1996, The Journal of clinical investigation.
[2] P. Fu,et al. Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.
[3] R. Krauss,et al. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. , 1998, American journal of human genetics.
[4] A. Tall,et al. A Mouse Model with Features of Familial Combined Hyperlipidemia , 1997, Science.
[5] J. Todd,et al. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. , 2000, Genome research.
[6] J. Breslow,et al. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Brunak,et al. SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .
[8] C. Bult,et al. Functional annotation of a full-length mouse cDNA collection , 2001, Nature.
[9] W. Miller,et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. , 2000, Science.
[10] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[11] A. von Eckardstein,et al. Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia* , 1998, The Journal of Biological Chemistry.
[12] J. Breslow,et al. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. , 1994, The Journal of clinical investigation.
[13] K. Frazer,et al. The apolipoprotein(a) gene is regulated by sex hormones and acute–phase inducers in YAC transgenic mice , 1995, Nature Genetics.
[14] A. Lupas,et al. Predicting coiled coils from protein sequences , 1991, Science.
[15] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[16] R J Havel,et al. Introduction to the plasma lipoproteins. , 1986, Methods in enzymology.
[17] G. Bruns,et al. Human Apolipoprotein A‐I‐C‐III Gene Complex is Located on Chromosome II , 1984, Arteriosclerosis.
[18] R. Krauss,et al. Triglycerides and atherogenic lipoproteins: rationale for lipid management. , 1998, The American journal of medicine.
[19] Hao Li,et al. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. , 1994, The Journal of biological chemistry.
[20] J. Trottier,et al. Overexpression of Human Apolipoprotein A-II in Mice Induces Hypertriglyceridemia Due to Defective Very Low Density Lipoprotein Hydrolysis* , 1999, The Journal of Biological Chemistry.
[21] P. Denéfle,et al. Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV , 1996, Science.
[22] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[23] Lior Pachter,et al. VISTA : visualizing global DNA sequence alignments of arbitrary length , 2000, Bioinform..
[24] E. Rubin,et al. Lethal α–thalassaemia created by gene targeting in mice and its genetic rescue , 1995, Nature Genetics.
[25] J. Breslow,et al. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. , 1990, Science.
[26] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.
[27] R. Lewontin,et al. On measures of gametic disequilibrium. , 1988, Genetics.
[28] R. Krauss,et al. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. , 1994, The American journal of clinical nutrition.
[29] M. Hayden,et al. DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias. , 1987, American journal of human genetics.
[30] J. Taylor,et al. Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice. , 1996, Journal of lipid research.
[31] E. Rubin,et al. Perspectives for vascular genomics , 2000, Nature.
[32] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[33] P. D. de Jong,et al. Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. , 2000, Genome research.
[34] R. Krauss,et al. LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[35] P Green,et al. Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.
[36] E. Rubin,et al. Contrasting in Vivo Effects of Murine and Human Apolipoprotein A-II , 1996, The Journal of Biological Chemistry.
[37] M. Farrall,et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24 , 1991, Nature.
[38] D. Nickerson,et al. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.